Dr Seth Baum interviews Dr Mikhail Kosiborod about clinical trial data surrounding the possible mechanisms of action of SLGT2 inhibitors for heart failure, as well as the cardio-renal connection.
Dr Seth Baum, president of the American Society for Preventive Cardiology, welcomes you to our new podcast series and leaves clinicians with a tip for gaining access to heart failure medication.
Lawrence Appel, MD, from John's Hopkins University, answers our questions about a new report about the impact of diet on brain health among older adults.
Recently, Consultant360 spoke with Dr Wilbert S. Aronow, who was part of the panel that constructed the new hypertension guidelines, about the factors that help determine appropriate treatment options for...
Low physical activity levels lead to obesity and other comorbidities. On the other end of the spectrum, too much exercise may not be good for the heart either, according to a recent study. The lead author...
Thomas Seck, MD, from Boehringer Ingelheim, spoke with us about the results of the landmark EMPA-REG OUTCOME trial and what they mean for the treatment of diabetes and cardiovascular disease.
Thomas Seck, MD, from Boehringer Ingelheim, spoke with us about the results of the landmark EMPA-REG OUTCOME trial and what they mean for the treatment of diabetes and cardiovascular disease.
<p>Dr Kevin Maki, from Midwest Biomedical Research, speaks to us about his latest review about the effect of omega3 supplementation on cardiometabolic health.</p>
